p.79 抽出テキスト
diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes Endocrinol 2019;7:344–355. https://doi.org/10.1016/S2213-8587(19)30068-3 80. Bloomfield HE, Koeller E, Greer N, MacDonald R, Kane R, Wilt TJ. Effects on health outcomes of a Mediterranean diet with no restriction on fat intake: a systematic review and meta-analysis. Ann Intern Med 2016;165:491–500. https://doi.org/10.7326/M16- 0361 81. Sacks FM, Lichtenstein AH, Wu JH, Appel LJ, Creager MA, Kris-Etherton PM, et al. Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association. Circulation 2017;136:e1–e23. https://doi.org/10.1161/CIR. 0000000000000510 82. Estruch R, Ros E, Salas-Salvadó J, Covas M-I, Corella D, Arós F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extravirgin olive oil or nuts. N Engl J Med 2018;378:e34. https://doi.org/10.1056/ NEJMoa1800389 83. Qian F, Liu G, Hu FB, Bhupathiraju SN, Sun Q. Association between plant-based dietary patterns and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA Intern Med 2019;179:1335–1344. https://doi.org/10.1001/jamainternmed.2019.2195 84. Willett W, Rockström J, Loken B, Springmann M, Lang T, Vermeulen S, et al. Food in the Anthropocene: the EAT–Lancet Commission on healthy diets from sustainable food systems. Lancet 2019;393:447–492. https://doi.org/10.1016/S0140-6736(18) 31788-4 85. Delgado-Lista J, Alcala-Diaz JF, Torres-Peña JD, Quintana-Navarro GM, Fuentes F, Garcia-Rios A, et al. Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial. Lancet 2022;399:1876–1885. https://doi.org/10.1016/S0140-6736(22)00122-2 86. Bosch J, Gerstein HC, Dagenais GR, Díaz R, Dyal L, Jung H, et al. n–3 Fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 2012;367: 309–318. https://doi.org/10.1056/NEJMoa1203859 87. ASCEND Study Collaborative Group. Effects of n−3 fatty acid supplements in diabetes mellitus. N Engl J Med 2018;379:1540–1550. https://doi.org/10.1056/NEJMoa1804989 88. Malik VS, Li Y, Pan A, De Koning L, Schernhammer E, Willett WC, et al. Long-term consumption of sugar-sweetened and artificially sweetened beverages and risk of mortality in US adults. Circulation 2019;139:2113–2125. https://doi.org/10.1161/ CIRCULATIONAHA.118.037401 89. Mullee A, Romaguera D, Pearson-Stuttard J, Viallon V, Stepien M, Freisling H, et al. Association between soft drink consumption and mortality in 10 European countries. JAMA Intern Med 2019;179:1479–1490. https://doi.org/10.1001/jamainternmed.2019. 2478 90. Wood AM, Kaptoge S, Butterworth AS, Willeit P, Warnakula S, Bolton T, et al. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet 2018;391: 1513–1523. https://doi.org/10.1016/S0140-6736(18)30134-X 91. Millwood IY, Walters RG, Mei XW, Guo Y, Yang L, Bian Z, et al. Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China. Lancet 2019;393:1831–1842. https://doi.org/10.1016/ S0140-6736(18)31772-0 92. Holmes MV, Dale CE, Zuccolo L, Silverwood RJ, Guo Y, Ye Z, et al. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ 2014;349:g4164. https://doi.org/10.1136/bmj.g4164 93. Evangelista LS, Jose MM, Sallam H, Serag H, Golovko G, Khanipov K, et al. High-protein vs. standard-protein diets in overweight and obese patients with heart failure and diabetes mellitus: findings of the Pro-HEART trial. ESC Heart Fail 2021;8:1342–1348. https://doi.org/10.1002/ehf2.13213 94. Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis EJ, et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care 2014;37(Suppl 1):S120–S143. https://doi.org/10.2337/dc14-S120 95. He FJ, Tan M, Ma Y, MacGregor GA. Salt reduction to prevent hypertension and cardiovascular disease: JACC state-of-the-art review. J Am College Cardiol 2020;75: 632–647. https://doi.org/10.1016/j.jacc.2019.11.055 96. Neal B, Wu Y, Feng X, Zhang R, Zhang Y, Shi J, et al. Effect of salt substitution on cardiovascular events and death. N Engl J Med 2021;385:1067–1077. https://doi.org/10. 1056/NEJMoa2105675 97. Sluik D, Buijsse B, Muckelbauer R, Kaaks R, Teucher B, Tj A, et al. Physical activity and mortality in individuals with diabetes mellitus: a prospective study and meta-analysis. Arch Intern Med 2012;172:1285–1295. https://doi.org/10.1001/archinternmed.2012. 3130 98. Wahid A, Manek N, Nichols M, Kelly P, Foster C, Webster P, et al. Quantifying the association between physical activity and cardiovascular disease and diabetes: a systematic review and meta-analysis. J Am Heart Assoc 2016;5:e002495. https://doi.org/ 10.1161/JAHA.115.002495 99. Arem H, Moore SC, Patel A, Hartge P, De Gonzalez AB, Visvanathan K, et al. Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship. JAMA Intern Med 2015;175:959–967. https://doi.org/10.1001/jamainternmed.2015.0533 100. Hupin D, Roche F, Gremeaux V, Chatard J-C, Oriol M, Gaspoz J-M, et al. Even a lowdose of moderate-to-vigorous physical activity reduces mortality by 22% in adults aged≥ 60 years: a systematic review and meta-analysis. Br J Sports Med 2015;49: 1262–1267. https://doi.org/10.1136/bjsports-2014-094306 101. Church TS, Blair SN, Cocreham S, Johannsen N, Johnson W, Kramer K, et al. Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial. JAMA 2010;304:2253–2262. https://doi.org/10. 1001/jama.2010.1710 102. Pelliccia A, Sharma S, Gati S, Bäck M, Börjesson M, Caselli S, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease: the Task Force on sports cardiology and exercise in patients with cardiovascular disease of the European Society of Cardiology (ESC). Eur Heart J 2021;42:17–96. https://doi. org/10.1093/eurheartj/ehaa605 103. Colberg SR, Sigal RJ, Yardley JE, Riddell MC, Dunstan DW, Dempsey PC, et al. Physical activity/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care 2016;39:2065–2079. https://doi.org/10.2337/dc16-1728 104. Ambrosetti M, Abreu A, Corrà U, Davos CH, Hansen D, Frederix I, et al. Secondary prevention through comprehensive cardiovascular rehabilitation: from knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol 2021;28:460–495. https://doi.org/10.1177/2047487320913379 105. Karstoft K, Winding K, Knudsen SH, Nielsen JS, Thomsen C, Pedersen BK, et al. The effects of free-living interval-walking training on glycemic control, body composition, and physical fitness in type 2 diabetic patients: a randomized, controlled trial. Diabetes Care 2013;36:228–236. https://doi.org/10.2337/dc12-0658 106. Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee I-M, et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 2011;43:1334–1359. https://doi.org/10.1249/mss.0b013e318213fefb 107. Hansen D, Abreu A, Ambrosetti M, Cornelissen V, Gevaert A, Kemps H, et al. Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol 2022;29:230–245. https://doi.org/10.1093/eurjpc/zwab007 108. Kemps H, Kränkel N, Dörr M, Moholdt T, Wilhelm M, Paneni F, et al. Exercise training for patients with type 2 diabetes and cardiovascular disease: what to pursue and how to do it. A Position Paper of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol 2019;26:709–727. https://doi.org/10.1177/2047487318820420 109. Scherr J, Wolfarth B, Christle JW, Pressler A, Wagenpfeil S, Halle M. Associations between Borg’s rating of perceived exertion and physiological measures of exercise intensity. Eur J Appl Physiol 2013;113:147–155. https://doi.org/10.1007/s00421-012-2421-x 110. Kraus WE, Powell KE, Haskell WL, Janz KF, Campbell WW, Jakicic JM, et al. Physical activity, all-cause and cardiovascular mortality, and cardiovascular disease. Med Sci Sports Exerc 2019;51:1270. https://doi.org/10.1249/MSS.0000000000001939 111. Jakicic JM, Kraus WE, Powell KE, Campbell WW, Janz KF, Troiano RP, et al. Association between bout duration of physical activity and health: systematic review. Med Sci Sports Exerc 2019;51:1213. https://doi.org/10.1249/MSS.0000000000001933 112. Cradock KA, ÓLaighin G, Finucane FM, Gainforth HL, Quinlan LR, Ginis KAM. Behaviour change techniques targeting both diet and physical activity in type 2 diabetes: a systematic review and meta-analysis. Int J Behav Nutr Phys Act 2017;14:18. https://doi.org/10.1186/s12966-016-0436-0 113. Howlett N, Trivedi D, Troop NA, Chater AM. Are physical activity interventions for healthy inactive adults effective in promoting behavior change and maintenance, and which behavior change techniques are effective? A systematic review and meta-analysis. Transl Behav Med 2019;9:147–157. https://doi.org/10.1093/tbm/iby010 114. Brickwood K-J, Watson G, O’Brien J, Williams AD. Consumer-based wearable activity trackers increase physical activity participation: systematic review and meta-analysis. JMIR mHealth uHealth 2019;7:e11819. https://doi.org/10.2196/11819 115. Mannucci E, Bonifazi A, Monami M. Comparison between different types of exercise training in patients with type 2 diabetes mellitus: a systematic review and network metanalysis of randomized controlled trials. Nutr Metab Cardiovasc Dis 2021;31: 1985–1992. https://doi.org/10.1016/j.numecd.2021.02.030 116. Murray EM, Whellan DJ, Chen H, Bertoni AG, Duncan P, Pastva AM, et al. Physical rehabilitation in older patients hospitalized with acute heart failure and diabetes: insights from REHAB-HF. Am J Med 2022;135:82–90. https://doi.org/10.1016/j.amjmed.2021. 08.001 117. Yang Z, Scott CA, Mao C, Tang J, Farmer AJ. Resistance exercise versus aerobic exercise for type 2 diabetes: a systematic review and meta-analysis. Sports Med 2014;44: 487–499. https://doi.org/10.1007/s40279-013-0128-8 118. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 2003;290:86–97. https://doi.org/10.1001/jama.290.1.86 119. Choi JW, Han E, Kim TH. Association of smoking cessation after new-onset type 2 diabetes with overall and cause-specific mortality among Korean men: a nationwide population-based cohort study. BMJ Open Diabetes Res Care 2020;8:e001249. https://doi.org/10.1136/bmjdrc-2020-001249 ESC Guidelines 4121 Downloaded from academic.oup.com/eurheartj/article/44/39/4043/7238227 by guest on 07 October 2026